Determining the Interaction in a Drug Combination using the Dose-based or Effect-based Method

References

1. ChouT.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.Pharmacol. Rev.200658362168110.1124/pr.58.3.10 16968952
   [Google Scholar]
2. ChouT.C. Drug combination studies and their synergy quantification using the Chou-Talalay method.Cancer Res.201070244044610.1158/0008‑5472.CAN‑09‑1947 20068163
   [Google Scholar]
3. BIOSOFTCalcuSyn for windows: Software for dose effect analysis.1996-2005.
   [Google Scholar]
4. JinZ.J. About the evaluation of drug combination.Acta Pharmacol. Sin.2004252146147 14769200
   [Google Scholar]
5. LiuQ. ZhongX. ZhangY. LiX. QianG. YuT. Ultrasound enhances ZD2767P‒carboxypeptidase G2 against chemoresistant ovarian cancer cells by altering the intracellular pharmacokinetics of ZD2767D.Mol. Pharm.20201761922193210.1021/acs.molpharmaceut.0c00008 32302486
   [Google Scholar]
6. LiuQ. LiX. LuoY. WangH. ZhangY. YuT. Ultrasonically enhanced ZD2767P‒carboxypeptidase G2 deactivates cisplatin-resistant human lung cancer cells.Oxid. Med. Cell. Longev.20222022919123310.1155/2022/9191233 36388164
   [Google Scholar]
7. YuT. LiX. Clinical trials of high intensity focused ultrasound for cancers: Concerns arising from low post-hoc power.Curr. Med. Chem.20253212510.2174/0109298673281773240104142757 38323616
   [Google Scholar]
8. HussainY. SinghJ. MeenaA. SinhaR.A. LuqmanS. Escin-sorafenib synergy up-regulates LC3-II and p62 to induce apoptosis in hepatocellular carcinoma cells.Environ. Toxicol.202439284085610.1002/tox.23988 37853854
   [Google Scholar]
9. DuarteD. FalcãoS.I. El MehdiI. Vilas-BoasM. ValeN. Honeybee venom synergistically enhances the cytotoxic effect of CNS drugs in HT-29 colon and MCF-7 breast cancer cell lines.Pharmaceutics202214351110.3390/pharmaceutics14030511 35335887
   [Google Scholar]
10. FalcãoS.I. DuarteD. DialloM. SantosJ. RibeiroE. ValeN. Vilas-BoasM. Improvement of the in vitro cytotoxic effect on HT-29 colon cancer cells by combining 5-fluorouacil and fluphenazine with green, red or brown propolis.Molecules2023288339310.3390/molecules28083393 37110626
    [Google Scholar]
11. YuT. LiX. YuT. ChenM. SunY. RanR. Intracellular pharmacokinetics of activated drugs in a prodrug-enzyme-ultrasound system: Evaluations on ZD2767P+CPG2+US.ACS Med. Chem. Lett.202415573974510.1021/acsmedchemlett.4c00071 38746880
    [Google Scholar]
12. ZaccaraG. FrancoV. Pharmacokinetic interactions between antiseizure and psychiatric medications.Curr. Neuropharmacol.20232181666169010.2174/1570159X2066622052412164535611779
    [Google Scholar]
13. XieY. WangC. Herb-drug interactions between Panax notoginseng or its biologically active compounds and therapeutic drugs: A comprehensive pharmacodynamic and pharmacokinetic review.J. Ethnopharmacol.202330711615610.1016/j.jep.2023.116156 36754189
    [Google Scholar]
14. ZhangY. DengZ. XuX. FengY. ShangJ. Application of artificial intelligence in drug-drug interactions prediction: A review.J. Chem. Inf. Model.20246472158217310.1021/acs.jcim.3c00582 37458400
    [Google Scholar]
15. HaubenM. Artificial intelligence and data mining for the pharmacovigilance of drug-drug interactions.Clin. Ther.202345211713310.1016/j.clinthera.2023.01.002 36732152
    [Google Scholar]